Abstract Context The European Association of Urology (EAU) guidelines panel on upper
urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in …

CONTEXT: This review focuses on the prediction of recurrence and progression in non–
muscle invasive bladder cancer (NMIBC) and the treatments advocated for this disease …

INTRODUCTION:: The follow-up of patients with urothelial cell carcinoma (UCC) of the
bladder is done by cystoscopy and, in most cases, cytology. The last decade, many urine …

Bladder carcinoma is the most common malignancy of the urinary tract. Approximately 75–
85% of patients with bladder cancer present with a disease that is confined to the mucosa …

CONTEXT: Follow-up of patients treated for bladder cancer (BCa) is of great importance for
both non–muscle-invasive BCa (NMIBC) and muscle-invasive BCa (MIBC) because of the …

PURPOSE: We studied the relationship of first cystoscopy findings with recurrence and
progression rates in a large, population based series of patients with bladder cancer …

PURPOSE:: In the absence of clear evidence, surveillance of low grade superficial bladder
cancer by regular check cystoscopy may continue unnecessarily, or discharge from followup …

This initiative was undertaken in response to concerns regarding the variation in
management and in outcomes of patients with bladder cancer throughout centres and …

BACKGROUND It has been shown that microsatellite analysis (MA) is able to detect bladder
carcinoma in urine. Relatively small groups of patients often with high stage and grade …

Context Intermediate-risk (IR) non–muscle-invasive bladder cancer (NMIBC) is a
heterogeneous disease. Objective To update the International Bladder Cancer Group …